Gene: LMNB1
Official Full Name: lamin B1provided by HGNC
Gene Summary: This gene encodes one of the two B-type lamin proteins and is a component of the nuclear lamina. A duplication of this gene is associated with autosomal dominant adult-onset leukodystrophy (ADLD). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04117 | LMNB1 Knockout cell line (HeLa) | Human | LMNB1 | 1:3~1:6 | Negative | Online Inquiry |
KO04118 | LMNB1 Knockout cell line (HCT 116) | Human | LMNB1 | 1:2~1:4 | Negative | Online Inquiry |
KO04119 | LMNB1 Knockout cell line (HEK293) | Human | LMNB1 | 1:3~1:6 | Negative | Online Inquiry |
KO04120 | LMNB1 Knockout cell line (A549) | Human | LMNB1 | 1:3~1:4 | Negative | Online Inquiry |
LMNB1 Gene Knockout Cell Lines are specialized cellular models engineered to precisely disrupt the expression of the LMNB1 gene, which encodes lamin B1, a critical protein in maintaining nuclear structure and chromatin organization. By employing advanced CRISPR/Cas9 gene-editing technology, these cell lines facilitate the study of the consequences of LMNB1 loss, providing insights into cellular dynamics, gene regulation, and disease mechanisms.
The key functions of LMNB1 include supporting nuclear envelope integrity, regulating gene expression through chromatin organization, and playing a significant role in cellular responses to stress. The mechanisms underlying these roles are elucidated through comparative analyses of wild-type and LMNB1 knockout cell lines, allowing researchers to observe alterations in cellular morphology, proliferation rates, and gene expression profiles. Through such analyses, the implications of LMNB1 in oncogenic processes, neurodegenerative diseases, and developmental disorders can be explored.
The scientific importance of LMNB1 Gene Knockout Cell Lines is underscored by their applications in fundamental research, drug discovery, and translational medicine. They serve as powerful tools for dissecting the pathophysiology of diseases associated with nuclear envelope instability and chromosomal abnormalities. Additionally, these knockout models contribute to the development of targeted therapies by facilitating the screening of drug candidates that might selectively restore function or compensate for the loss of lamin B1.
Compared to other models, the unique selling points of LMNB1 Gene Knockout Cell Lines include their reliable performance, reproducibility, and the ability to closely mimic the physiological conditions present in living organisms. This provides a significant advantage over traditional cell lines lacking specific mutations or alterations, which may not adequately represent disease states.
Investing in LMNB1 Gene Knockout Cell Lines is essential for researchers and clinicians aiming to advance their understanding of nuclear biology and its implications in health and disease. With our expertise in providing high-quality biological products and innovative solutions for life sciences research, we ensure that our cell lines meet the rigorous demands of contemporary research, supporting breakthroughs in various biological and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.